In its Editorial of 10/11/2020, Le Figaro comes back on the regulatory “tsunami” imposed on the Medtech manufacturers. Several leaders of the DM sector were interviewed. For Peters Surgical, a French industrial mid-size Medtech founded in 1926, the new European regulation (MDR – Medical Device Regulation voted in May 2017) will result in the disappearance of 300 products from its catalog. It required the recruitment of 30 people in AR/QA/Quality/Validation & Clinical in the group. To cope with it, “We have chosen to focus on the most innovative products” said Thierry Herbreteau, CEO of the group.
Peters Surgical was able to benefit from Innov’up program funding for research on a bio-sourced haemostatic glue.